Home › Compare › LSB vs O

LSB vs O: Dividend Comparison 2026

LSB yields 318.98% · O yields 5.28%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 LSB wins by $2296.48M in total portfolio value
10 years
LSB
LSB
● Live price
318.98%
Share price
$0.63
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$2296.51M
Annual income
$1,420,493,114.32
Full LSB calculator →
O
Realty Income Corporation
● Live price
5.28%
Share price
$61.15
Annual div
$3.23
5Y div CAGR
15.1%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$34.2K
Annual income
$5,102.74
Full O calculator →

Portfolio growth — LSB vs O

📍 LSB pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodLSBO
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, LSB + O cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
LSB pays
O pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

LSB
Annual income on $10K today (after 15% tax)
$27,113.24/yr
After 10yr DRIP, annual income (after tax)
$1,207,419,147.17/yr
O
Annual income on $10K today (after 15% tax)
$449.12/yr
After 10yr DRIP, annual income (after tax)
$4,337.33/yr
At 15% tax rate, LSB beats the other by $1,207,414,809.84/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of LSB + O for your $10,000?

LSB: 50%O: 50%
100% O50/50100% LSB
Portfolio after 10yr
$1148.27M
Annual income
$710,249,108.53/yr
Blended yield
61.85%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on O right now

LSB
No analyst data
Altman Z
-2.7
Piotroski
2/9
O
Analyst Ratings
13
Buy
18
Hold
3
Sell
Consensus: Hold
Price Target
$64.00
+4.7% upside vs current
Range: $60.00 — $69.00
Altman Z
1.0
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

LSB buys
0
O buys
0
No recent congressional trades found for LSB or O in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricLSBO
Forward yield318.98% ✓5.28%
Annual dividend / share$2.00$3.23 ✓
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%15.1% ✓
Portfolio after 10y$2296.51M ✓$34.2K
Annual income after 10y$1,420,493,114.32 ✓$5,102.74
Total dividends collected$2210.37M ✓$20.7K
Payment frequencyquarterlymonthly
SectorStockREIT

Year-by-year: LSB vs O ($10,000, DRIP)

YearLSB PortfolioLSB Income/yrO PortfolioO Income/yrGap
1← crossover$42,598$31,897.93$10,818$608.16+$31.8K → LSB
2$172,569$126,989.30$11,787$741.68+$160.8K → LSB
3$665,442$480,792.73$12,946$911.00+$652.5K → LSB
4$2,444,714$1,732,690.93$14,345$1,127.94+$2.43M → LSB
5$8,564,999$5,949,155.42$16,056$1,409.05+$8.55M → LSB
6$28,643,738$19,479,189.22$18,171$1,777.83+$28.63M → LSB
7$91,530,880$60,882,080.00$20,820$2,268.21+$91.51M → LSB
8$279,758,876$181,820,834.73$24,188$2,929.90+$279.73M → LSB
9$818,711,097$519,369,100.17$28,533$3,837.11+$818.68M → LSB
10$2,296,513,989$1,420,493,114.32$34,235$5,102.74+$2296.48M → LSB

LSB vs O: Complete Analysis 2026

LSB — Stock

LakeShore Biopharma Co., Ltd, a biopharmaceutical company, engages in discovering, developing, manufacturing, and commercializing of vaccines and therapeutic biologics for infectious diseases and cancer. The company develops a proprietary PIKA immunomodulating technology platform and a series of product targeting PIKA rabies vaccine, PIKA recombinant COVID-19 vaccine, and PIKA YS-ON-001. It operates in China, the United States, Singapore, the United Arab Emirates, and the Philippines. The company was formerly known as YS Biopharma Co., Ltd. and changed its name to LakeShore Biopharma Co., Ltd in May 2024. LakeShore Biopharma Co., Ltd was founded in 2002 and is based in Beijing, China.

Full LSB Calculator →

O — REIT

Realty Income, The Monthly Dividend Company, is an S&P 500 company dedicated to providing stockholders with dependable monthly income. The company is structured as a REIT, and its monthly dividends are supported by the cash flow from over 6,500 real estate properties owned under long-term lease agreements with our commercial clients. To date, the company has declared 608 consecutive common stock monthly dividends throughout its 52-year operating history and increased the dividend 109 times since Realty Income's public listing in 1994 (NYSE: O). The company is a member of the S&P 500 Dividend Aristocrats index. Additional information about the company can be obtained from the corporate website at www.realtyincome.com.

Full O Calculator →
📬

Get this LSB vs O comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

LSB vs SCHDLSB vs JEPILSB vs KOLSB vs MAINLSB vs STAGLSB vs ADCLSB vs NNNLSB vs VICI

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.